| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001523590 |
| P356 | DOI | 10.1007/S13277-011-0221-2 |
| P698 | PubMed publication ID | 21853312 |
| P2093 | author name string | Qi Wang | |
| Xin Wang | |||
| Shu Zheng | |||
| Hai Liu | |||
| Jian-Bin Hu | |||
| Xiao-Nan Sun | |||
| Wei-Guo Cao | |||
| Qi-Chu Yang | |||
| Ben-Xing Gu | |||
| P2860 | cites work | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 |
| Cancer statistics, 2010 | Q27860525 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis | Q29620559 | ||
| Strategies for surgical treatment of gallbladder carcinoma based on information available before resection | Q35177785 | ||
| Gallbladder cancer: lessons from a rare tumour | Q35877178 | ||
| Bax expression is a candidate prognostic and predictive marker of colorectal cancer | Q36097096 | ||
| Chemoradiotherapy in gallbladder cancer | Q36488844 | ||
| Prognostic significance of angiogenesis in human pancreatic cancer | Q36619020 | ||
| Long-term results after resection for gallbladder cancer. Implications for staging and management | Q41210311 | ||
| Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer | Q42544217 | ||
| Adjuvant chemoradiation therapy in gallbladder cancer | Q43005759 | ||
| Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors | Q43799030 | ||
| Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma | Q43845693 | ||
| Prognostic factors for gallbladder cancer in Japan | Q44569120 | ||
| Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas | Q44660500 | ||
| Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience | Q45881932 | ||
| Postoperative adjuvant treatments for biliary tract cancer | Q46330636 | ||
| Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). | Q46358438 | ||
| Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience | Q46576911 | ||
| Epidemiology of gallbladder cancer. | Q47709235 | ||
| Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience | Q50164226 | ||
| Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer | Q50177638 | ||
| Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention | Q50186302 | ||
| Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. | Q53206208 | ||
| Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. | Q54154169 | ||
| Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomas | Q58211872 | ||
| Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis | Q58212439 | ||
| Gallstones and glaciers: the stone that came in from the cold | Q69919313 | ||
| Lymph node spread from carcinoma of the gallbladder | Q73605889 | ||
| Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma | Q73841991 | ||
| Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer | Q73886958 | ||
| Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer | Q74430086 | ||
| Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer | Q74505899 | ||
| Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma | Q74641036 | ||
| Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer | Q77726950 | ||
| Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas | Q78204868 | ||
| [The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma] | Q84296284 | ||
| P433 | issue | 6 | |
| P921 | main subject | gallbladder carcinoma | Q18556564 |
| P304 | page(s) | 1183-1190 | |
| P577 | publication date | 2011-08-19 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma | |
| P478 | volume | 32 |
| Q43193059 | Adjuvant treatment in biliary tract cancer: to treat or not to treat? |
| Q87161553 | Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer |
| Q33805874 | Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update |
| Q55386854 | Investigation of targetable predictive and prognostic markers in gallbladder carcinoma. |
| Q100490609 | Overview of current targeted therapy in gallbladder cancer |
| Q35012106 | Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma |
| Q30398807 | Targeting Angiogenesis in Biliary Tract Cancers: An Open Option |
| Q49657838 | Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy |
Search more.